Kumar, S., Mehta, R. and Sah, R. (2025) “Commentary on “Pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors”, Clinics, 80, p. 100651. doi:10.1590/.